 | Up a level |
Robaeys, G.; Grebely, J.; Mauss, S.; Bruggmann, P.; Moussalli, J.; De Gottardi, Andrea; Swan, T.; Arain, A.; Kautz, A.; Stover, H.; Wedemeyer, H.; Schaefer, M.; Taylor, L.; Backmund, M.; Dalgard, O.; Prins, M.; Dore, G. J. (2013). Recommendations for the Management of Hepatitis C Virus Infection Among People Who Inject Drugs. Clinical infectious diseases, 57(Suppl 2), S129-S137. Oxford University Press 10.1093/cid/cit302
Bruggmann, P.; Falcato, L.; Dober, S.; Helbling, B.; Keiser, O.; Negro, F.; Meili, D. (2008). Active intravenous drug use during chronic hepatitis C therapy does not reduce sustained virological response rates in adherent patients. Journal of viral hepatitis, 15(10), pp. 747-752. Blackwell Science 10.1111/j.1365-2893.2008.01010.x
